| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
93,798 |
87,077 |
$5.69M |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
116,034 |
110,347 |
$2.47M |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
114,560 |
108,943 |
$2.44M |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
107,337 |
102,418 |
$2.23M |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
38,151 |
36,664 |
$1.76M |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
87,008 |
84,353 |
$1.49M |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
68,992 |
19,146 |
$1.20M |
| 87481 |
|
76,571 |
36,801 |
$1.12M |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
19,231 |
17,112 |
$1.06M |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
5,406 |
5,160 |
$915K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
48,307 |
45,304 |
$913K |
| 81420 |
Fetal chromosomal aneuploidy genomic sequence analysis panel |
3,662 |
3,447 |
$841K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
39,885 |
38,612 |
$823K |
| 87653 |
|
36,960 |
35,990 |
$795K |
| 81220 |
CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants |
2,748 |
2,558 |
$774K |
| 87511 |
|
25,274 |
24,369 |
$410K |
| 36415 |
Collection of venous blood by venipuncture |
273,335 |
244,086 |
$403K |
| 88307 |
|
3,076 |
2,613 |
$358K |
| 87529 |
|
13,059 |
7,562 |
$315K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
3,406 |
3,252 |
$261K |
| 88185 |
|
576 |
394 |
$155K |
| 87625 |
|
6,421 |
6,232 |
$139K |
| 88141 |
|
10,790 |
10,328 |
$136K |
| 88342 |
|
2,968 |
2,339 |
$118K |
| 88341 |
|
1,344 |
1,185 |
$110K |
| 88312 |
|
2,115 |
1,866 |
$89K |
| 87522 |
Neg quan hep c or qual rna |
2,994 |
2,917 |
$86K |
| 88304 |
|
3,084 |
2,753 |
$81K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
1,129 |
1,106 |
$80K |
| 81513 |
|
879 |
835 |
$63K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,316 |
2,252 |
$61K |
| 88142 |
|
3,939 |
3,832 |
$57K |
| 88374 |
|
241 |
199 |
$55K |
| 81329 |
|
1,423 |
1,273 |
$35K |
| 87563 |
|
2,175 |
2,088 |
$27K |
| 88189 |
|
438 |
364 |
$21K |
| 87536 |
|
489 |
469 |
$19K |
| 88112 |
|
629 |
522 |
$19K |
| 83020 |
|
3,089 |
3,004 |
$18K |
| 88184 |
|
513 |
394 |
$16K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,170 |
1,124 |
$16K |
| 87902 |
|
139 |
133 |
$14K |
| 88302 |
|
747 |
651 |
$14K |
| 87640 |
|
565 |
467 |
$12K |
| 81511 |
|
2,860 |
2,745 |
$12K |
| 88360 |
|
156 |
102 |
$8K |
| 88313 |
|
90 |
69 |
$8K |
| 87493 |
|
207 |
204 |
$6K |
| 87510 |
|
515 |
501 |
$6K |
| 87480 |
|
489 |
477 |
$6K |
| 88275 |
|
82 |
82 |
$6K |
| 87660 |
|
432 |
421 |
$5K |
| 81422 |
|
1,236 |
1,154 |
$4K |
| 87521 |
Neg quan hep c or qual rna |
136 |
131 |
$4K |
| 88311 |
|
248 |
214 |
$2K |
| 88271 |
|
82 |
82 |
$2K |
| 88291 |
|
114 |
109 |
$1K |
| G0452 |
Molecular pathology procedure; physician interpretation and report |
134 |
63 |
$878.79 |
| 81243 |
|
20 |
20 |
$872.16 |
| 81241 |
|
78 |
76 |
$840.95 |
| 84165 |
|
211 |
203 |
$818.28 |
| 85060 |
|
41 |
36 |
$509.38 |
| 88280 |
|
31 |
27 |
$484.57 |
| 88300 |
|
13 |
12 |
$134.43 |
| 81219 |
|
27 |
26 |
$110.68 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,020 |
921 |
$70.32 |
| G0145 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
125 |
124 |
$29.51 |
| 81001 |
|
1,955 |
1,811 |
$7.90 |
| 87210 |
|
247 |
240 |
$0.00 |
| 85007 |
|
20 |
12 |
$0.00 |
| 85610 |
|
1,075 |
731 |
$0.00 |
| 0761T |
|
395 |
323 |
$0.00 |
| 0753T |
|
3,851 |
3,349 |
$0.00 |
| 0752T |
|
470 |
395 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
569 |
555 |
$0.00 |
| 81003 |
|
745 |
701 |
$0.00 |
| 86900 |
|
283 |
253 |
$0.00 |
| 84100 |
|
795 |
260 |
$0.00 |
| 81269 |
|
54 |
49 |
$0.00 |
| 87186 |
|
446 |
321 |
$0.00 |
| 85049 |
|
38 |
24 |
$0.00 |
| 0760T |
|
653 |
544 |
$0.00 |
| 84702 |
|
74 |
66 |
$0.00 |
| 85380 |
|
67 |
64 |
$0.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
24 |
24 |
$0.00 |
| 83690 |
|
1,273 |
1,126 |
$0.00 |
| 84132 |
|
203 |
107 |
$0.00 |
| 80320 |
|
888 |
788 |
$0.00 |
| 82330 |
|
882 |
302 |
$0.00 |
| 85730 |
|
638 |
345 |
$0.00 |
| 82803 |
|
533 |
245 |
$0.00 |
| 83605 |
|
1,219 |
503 |
$0.00 |
| 80053 |
Comprehensive metabolic panel |
3,044 |
2,521 |
$0.00 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
702 |
656 |
$0.00 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
3,738 |
1,831 |
$0.00 |
| 80329 |
|
985 |
438 |
$0.00 |
| 84484 |
|
1,604 |
911 |
$0.00 |
| 85027 |
|
6,209 |
3,685 |
$0.00 |
| 83735 |
|
971 |
395 |
$0.00 |
| 87070 |
|
837 |
740 |
$0.00 |
| 84703 |
|
1,776 |
1,621 |
$0.00 |
| 87077 |
|
270 |
182 |
$0.00 |
| 0756T |
|
106 |
86 |
$0.00 |
| 86901 |
|
143 |
125 |
$0.00 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
198 |
181 |
$0.00 |
| 87040 |
|
866 |
356 |
$0.00 |
| 0754T |
|
1,277 |
945 |
$0.00 |
| 86850 |
|
90 |
78 |
$0.00 |
| 0751T |
|
156 |
116 |
$0.00 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
42 |
40 |
$0.00 |
| 81596 |
|
13 |
13 |
$0.00 |
| 83880 |
|
92 |
86 |
$0.00 |
| 87205 |
|
21 |
15 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
58 |
55 |
$0.00 |